NCT00931710
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension
See it on ClinicalTrials.gov ↗488 people
43.6%
56.4%
213 womenmiddle line = equal numbers275 men
- Phase
- PHASE4
- Paid for by
- Novartis
- Finished
- 2010-01
- Health conditions
- Stage 2 Systolic Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – no maximum
- Average age
- mean 56.1 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
No rules that kept women out were found.
Study titles and rules are shown in their original English.